Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONDK
3676
DELISTED
On Deck Capital, Inc.
ONDK
| $242K | ﹤0.01% |
151,482
+135,617
| +855% | +$184K |
|
|
LITS
3677
Lite Strategy Inc
LITS
$30.2M
| $241K | ﹤0.01% |
3,870
-485
| -11% | -$29.2K |
|
3678
Titan Machinery
TITN
$429M
| $240K | ﹤0.01% |
18,134
-1,765
| -9% | -$21.4K |
|
3679
Oil States International
OIS
$539M
| $239K | ﹤0.01% |
87,252
+14,215
| +19% | +$61.7K |
|
3680
Center Bancorp
CNOB
$1.79B
| $238K | ﹤0.01% |
16,968
-3,464
| -17% | -$50.4K |
|
3681
PUT
Gold Fields
GFI
$36B
| $237K | ﹤0.01% |
19,300
| – | – |
|
3682
Gorman-Rupp
GRC
$2.13B
| $237K | ﹤0.01% |
8,058
+8,026
| +25,081% | +$253K |
|
3683
iShares MSCI India ETF
INDA
$6.56B
| $237K | ﹤0.01% |
6,985
-19,500
| -74% | -$638K |
|
|
SP
3684
DELISTED
SP Plus Corporation
SP
| $237K | ﹤0.01% |
13,146
-2,103
| -14% | -$38.6K |
|
3685
Dillards
DDS
$8.76B
| $236K | ﹤0.01% |
6,451
-7,404
| -53% | -$208K |
|
3686
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
| $236K | ﹤0.01% |
4,269
-3,000
| -41% | -$166K |
|
|
FFWM
3687
DELISTED
First Foundation Inc
FFWM
| $236K | ﹤0.01% |
18,042
-5,374
| -23% | -$81.6K |
|
3688
Albertsons Companies
ACI
$6.03B
| $235K | ﹤0.01% |
16,987
-2,898
| -15% | -$42.3K |
|
3689
CALL
BioCryst Pharmaceuticals
BCRX
$2.49B
| $235K | ﹤0.01% |
68,400
-83,700
| -55% | -$359K |
|
3690
Celestica
CLS
$42.3B
| $235K | ﹤0.01% |
+34,100
| New | +$256K |
|
3691
Hooker Furnishings Corp
HOFT
$158M
| $234K | ﹤0.01% |
9,080
-10,374
| -53% | -$243K |
|
3692
Dianthus Therapeutics
DNTH
$6.49B
| $233K | ﹤0.01% |
2,151
+788
| +58% | +$93.4K |
|
3693
CALL
Consolidated Edison
ED
$40.2B
| $233K | ﹤0.01% |
3,000
| – | – |
|
|
SAGE
3694
DELISTED
Sage Therapeutics
SAGE
| $233K | ﹤0.01% |
3,806
-14,050
| -79% | -$712K |
|
|
MCBC
3695
DELISTED
Macatawa Bank Corp
MCBC
| $233K | ﹤0.01% |
35,670
-2,401
| -6% | -$17.3K |
|
3696
CALL
Jacobs Solutions
J
$16.9B
| $232K | ﹤0.01% |
3,022
| – | – |
|
3697
Shore Bancshares
SHBI
$800M
| $232K | ﹤0.01% |
21,206
+5,375
| +34% | +$53.8K |
|
3698
PUT
Sonos
SONO
$1.93B
| $232K | ﹤0.01% |
15,300
| – | – |
|
3699
Ocular Therapeutix
OCUL
$2.2B
| $231K | ﹤0.01% |
30,447
+876
| +3% | +$7.27K |
|
3700
Bally's
BALY
$685M
| $230K | ﹤0.01% |
8,745
-18,094
| -67% | -$421K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.